Fluvoxamine Open-Label Treatment of Adolescent Inpatients with Obsessive-Compulsive Disorder or Depression

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 33, Issue 3, 1994, Pages 342-348

  APTER, ALAN ^a   RATZONI, GIDI ^a   KING, ROBERT A ^a   WEIZMAN, ABRAHAM ^a   IANCU, IULIAN ^a   BINDER, MONICA ^a   RIDDLE, MARK A ^a  

^a NONE

Author keywords

adolescence; depression, OCD; fluvoxamine; serotonin reuptake inhibitors

Indexed keywords

FLUVOXAMINE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DERMATITIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HALLUCINATION; HUMAN; HYPERACTIVITY; INSOMNIA; MALE; OBSESSION; PRIORITY JOURNAL; RATING SCALE;

ADOLESCENT; CASE REPORT; DEPRESSIVE DISORDER; FEMALE; FLUVOXAMINE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMAN; MALE; OBSESSIVE-COMPULSIVE DISORDER; PREGNANCY; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0028219575     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199403000-00007     Document Type: Article

References (36)

1. Psychometric properties of K-SADS-P in an Israeli adolescent inpatient population
2. Treatment of ADHD with fluoxetine: a preliminary trial
3. An inventory for measuring depression
4. Measurement of side effects including tardive dyskinesia
5. Fluoxetine treatment of children and adults with autistic disorder and mental retardation
6. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial
7. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression
8. Clomipramine treatment of childhood obsessive-compulsive disorder
9. Serotonin uptake and serotonin uptake inhibition
10. The Eating Attitudes Test: an index of symptoms of anorexia nervosa
11. The Yale-Brown Obsessive Compulsive Scale: II. Validity
12. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability
13. Differential response of seven subjects with autistic disorder to clomipramine and desipramine
14. Fluoxetine treatment of anorexia nervosa: an open clinical trial
15. Fluvoxamin bei kindern und jugendlichen
16. Open trial of fluoxetine in obsessive-compulsive disorder
17. An open trial of fluoxetine in patients with anorexia nervosa
18. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment
19. Psychopharmacology of obsessive- compulsive disorder in Tourette syndrome
20. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder
21. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial
22. Fluoxetine treatment of obsessive compulsive disorder: an open clinical trial
23. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression
24. Clomipramine in autism: preliminary evidence of efficacy
25. Do some antidepressants promote suicide?
26. Psychopharmacologic treatment of child and adolescent obsessive compulsive disorder
27. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience
28. Behavioral side effects of fluoxetine in children and adolescents
29. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder
30. A children's global assessment scale (CGAS)
31. Adolescent depression: a placebo-controlled fluoxetine treatment study and followup
32. Antidepressant drugs and the emergence of suicidal tendencies
33. Denosologation of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders
34. Review of fluvoxamine safety database
35. The Overt Aggression Scale for the objective rating of verbal and physical aggression